Related Experiment Videos
Postoperative analgesia by intravenous clonidine
J M Bernard1, J L Hommeril, N Passuti
1Département d'Anesthésie-Réanimation Chirurgicale, Hôtel Dieu, Nantes, France.
Anesthesiology
|October 1, 1991
Summary
Intravenous clonidine effectively reduced postoperative pain and morphine requirements after spinal fusion. This alpha 2 adrenoreceptor agonist offers a nonopiate alternative for pain management, minimizing opioid side effects.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Clonidine, an alpha 2 adrenoreceptor agonist, possesses nonopiate antinociceptive properties.
- It presents a potential alternative for postoperative analgesia, aiming to avoid opioid-induced side effects.
Purpose of the Study:
- To evaluate the analgesic efficacy of intravenous clonidine in the postoperative period following spinal fusion.
- To compare pain scores and opioid requirements between clonidine and placebo groups.
Main Methods:
- Fifty patients undergoing spinal fusion were randomly assigned to receive either intravenous clonidine or a placebo.
- Pain was assessed using a visual analog scale, with morphine administered as needed.
- Hemodynamic parameters, blood gases, and plasma clonidine concentrations were monitored.
Main Results:
- The clonidine group experienced a significant decrease in pain scores compared to the placebo group.
- Patients receiving clonidine required significantly less morphine for pain management.
- Clonidine administration delayed the onset of pain and the first request for morphine.
Conclusions:
- Intravenous clonidine demonstrates significant analgesic properties in the postoperative setting after spinal fusion.
- Clonidine can reduce the need for opioid analgesics, offering a viable nonopiate option for pain control.
- Further research may explore clonidine's role in multimodal analgesia strategies.